CIBC Asset Management
NKTR icon

CIBC Asset Management’s Nektar Therapeutics NKTR Stock Holding History

CIBC Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-956
Closed -$32.4K – 1114
2022
Q4 		$32.4K Sell
956
-105
-10% -$5.08K ﹤0.01% 1041
2022
Q3 		$51K Hold
1,061
– – ﹤0.01% 1210
2022
Q2 		$60K Sell
1,061
-38
-3% -$2.4K ﹤0.01% 1224
2022
Q1 		$89K Hold
1,099
– – ﹤0.01% 1467
2021
Q4 		$223K Buy
+1,099
New +$238K ﹤0.01% 1309
2019
Q4 		– Sell
-935
Closed -$256K – 1229
2019
Q3 		$256K Sell
935
-2
-0.2% -$733 ﹤0.01% 909
2019
Q2 		$500K Buy
937
+27
+3% +$13.5K ﹤0.01% 743
2019
Q1 		$459K Sell
910
-13
-1% -$7.7K ﹤0.01% 746
2018
Q4 		$455K Buy
923
+2
+0.2% +$1.21K ﹤0.01% 704
2018
Q3 		$842K Sell
921
-7
-0.8% -$5.97K 0.01% 627
2018
Q2 		$679K Buy
928
+39
+4% +$45K ﹤0.01% 666
2018
Q1 		$1.42M Buy
889
+528
+146% +$680K 0.01% 491
2017
Q4 		$323K Sell
361
-388
-52% -$229K ﹤0.01% 799
2017
Q3 		$270K Buy
749
+58
+8% +$18.1K ﹤0.01% 834
2017
Q2 		$203K Hold
691
– – ﹤0.01% 920
2017
Q1 		$243K Hold
691
– – ﹤0.01% 844
2016
Q4 		$127K Buy
+691
New +$140K ﹤0.01% 927

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Asset Management's NKTR Position: Q1 2023 in Review

CIBC Asset Management sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 956 shares — an estimated $32.4K sold.

CIBC Asset Management first reported a position in NKTR in Q4 2016 and held it in 17 quarters. The position peaked at $1.42M in Q1 2018. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • CIBC Asset Management reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • CIBC Asset Management sold 956 Nektar Therapeutics shares in Q1 2023, an estimated $32.4K.
  • CIBC Asset Management first reported a position in Nektar Therapeutics in Q4 2016 and held it in 17 quarters.
  • CIBC Asset Management's Nektar Therapeutics position peaked at $1.42M in Q1 2018.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on CIBC Asset Management's 13F filing for Q1 2023, filed 12 May 2023.